EUCTR2011-005082-21-DE进行中（未招募）1 期
Targeted BEACOPP variants in patients with newly diagnosed advanced classical Hodgkin Lymphoma
niversity of Cologne0 个研究点开始时间: 2012年4月19日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Attempt of treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase: initially with a combination of nilotinib and interferon alpha followed by a nilotinib or interferon alpha maintenance therapyEUCTR2010-024262-22-DEFriedrich-Schiller-Universität Jena720
进行中（未招募）
1 期
Attempt of treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase: initially with a combination of nilotinib and interferon alpha followed by a nilotinib or interferon alpha maintenance therapychronic phase CMLMedDRA version: 16.0Level: LLTClassification code 10009700Term: CMLSystem Organ Class: 100000004864EUCTR2010-024262-22-CZFriedrich-Schiller-Universität Jena628
已完成
不适用
Clinical assessment of patients with a mutation in the IGSF1 geneNL-OMON41375eids Universitair Medisch Centrum30
终止
2 期
Cemdisiran and eculizumab dose-ranging study for paroxysmal nocturnal haemoglobinuriaParoxysmal nocturnal haemoglobinuria (PNH)Haematological DisordersParoxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]ISRCTN31882639niversity of Leeds9
招募中
2 期
eo- and adjuvant targeted therapy in BRAF-mutated anaplastic cancer of the thyroidBRAF V600-mutant anaplastic thyroid cancer10014713NL-OMON51864Academisch Medisch Centrum20